345 related articles for article (PubMed ID: 17955243)
21. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
22. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
23. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
Audard V; Lang P; Sahali D
Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
[TBL] [Abstract][Full Text] [Related]
24. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
[TBL] [Abstract][Full Text] [Related]
25. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
[TBL] [Abstract][Full Text] [Related]
26. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Campbell KN; Tumlin JA
Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
[TBL] [Abstract][Full Text] [Related]
27. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
28. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
Shankland SJ
Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
[TBL] [Abstract][Full Text] [Related]
29. Kidney-derived c-kit
Rangel EB; Gomes SA; Kanashiro-Takeuchi R; Saltzman RG; Wei C; Ruiz P; Reiser J; Hare JM
Sci Rep; 2018 Oct; 8(1):14723. PubMed ID: 30283057
[TBL] [Abstract][Full Text] [Related]
30. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
31. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
32. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
33. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
34. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
Boucher I; Yu W; Beaudry S; Negoro H; Tran M; Pollak MR; Henderson JM; Denker BM
Lab Invest; 2012 May; 92(5):662-75. PubMed ID: 22249312
[TBL] [Abstract][Full Text] [Related]
35. Podocyte injury and its consequences.
Nagata M
Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
[TBL] [Abstract][Full Text] [Related]
36. Detrimental effects of hypoxia on glomerular podocytes.
Singh AK; Kolligundla LP; Francis J; Pasupulati AK
J Physiol Biochem; 2021 May; 77(2):193-203. PubMed ID: 33835424
[TBL] [Abstract][Full Text] [Related]
37. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P
Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
[TBL] [Abstract][Full Text] [Related]
38. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
39. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
40. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
